#Spain #Barcelona #Antibiotics #IBS #UEG Week

Understanding the Link Between Antibiotic Use and IBS Risk

Introduction

A groundbreaking study unveiled today at the UEG Week 2026 in Barcelona highlights a concerning trend regarding the use of antibiotics from childhood to early adulthood and its potential link to Irritable Bowel Syndrome (IBS) in young adults. This study indicates that the risk of developing IBS is notably higher in individuals who have been prescribed antibiotics, suggesting that prescribing practices need to be reassessed.

Study Overview

Researchers analyzed data from 2,853 participants within the Swedish BAMSE birth cohort. Their analysis reviewed antibiotic prescriptions from 2005, when participants were aged 9 to 11, up until one year before assessing cases of IBS, around the age of 24. The findings were striking; 10% of participants reported experiencing IBS by the age of 24. The data revealed that those affected by IBS had received antibiotics at a significantly higher rate—87.8% of those with IBS compared to 80.2% without it.

Findings of the Study

The study established a clear correlation: individuals who received antibiotics during their childhood had a 1.5 times higher likelihood (95% CI: 1.0–2.2) of suffering from IBS than those who did not. Moreover, the risk increased with the number of antibiotic prescriptions. For instance:

• - Those with one or two prescriptions had a 1.3 times higher risk (95% CI: 0.9–2.0).
• - The risk rose to 1.6 times (95% CI: 1.0–2.4) for three to five prescriptions.
• - Participants receiving six or more prescriptions faced a staggering 1.7 times increased risk (95% CI: 1.1–2.6).

Notably, specific classes of antibiotics, like Tetracyclines and Cephalosporins, showed a significant association with IBS risk, even after adjusting for gender and family socioeconomic status. Each instance of Tetracycline use was linked to a 1.4 times higher risk (95% CI: 1.1–1.8), while three or more prescriptions of Cephalosporins were associated with a remarkable 6.0 times increased risk (95% CI: 1.9–18.8).

Possible Explanations

While the reasons behind this association were not extensively investigated, researchers speculate that the gut microbiome might play a pivotal role. Dr. Jessica Sjölund, the lead author, explained, "Previous studies suggest that antibiotics can alter the gut microbiome, which is thought to contribute to IBS. Therefore, alterations in gut microbiota could be a mechanism underlying the observed link to IBS."

Implications and Future Directions

Dr. Sjölund emphasized the importance of balancing the necessity of antibiotics in treating bacterial infections with prudent prescription practices. "Antibiotics remain a critical treatment for bacterial infections," she stated. "Our findings should not discourage their use when necessary but rather highlight the potential long-term effects of repeated use. This reinforces the need to avoid unnecessary prescriptions."

With the frequency of antibiotic prescriptions on the rise, this study serves as a vital reminder of the need for greater awareness regarding the potential long-term influences of antibiotic use on gut health. As the medical community continues to explore these connections, it is crucial to approach antibiotic treatments with a careful and informed perspective.

Conclusion

The results presented at UEG Week 2026 mark a significant contribution to our understanding of gastrointestinal health. As researchers delve deeper into the relationship between antibiotics and IBS, future studies will likely shed more light on this critical health issue, guiding better-prescribing practices that protect patients' long-term well-being.